These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22985697)

  • 1. Structural modification of siRNA for efficient gene silencing.
    Lee SJ; Son S; Yhee JY; Choi K; Kwon IC; Kim SH; Kim K
    Biotechnol Adv; 2013; 31(5):491-503. PubMed ID: 22985697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
    Lee SH; Chung BH; Park TG; Nam YS; Mok H
    Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy.
    Buyens K; Meyer M; Wagner E; Demeester J; De Smedt SC; Sanders NN
    J Control Release; 2010 Jan; 141(1):38-41. PubMed ID: 19737587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency.
    Kwon YJ
    Acc Chem Res; 2012 Jul; 45(7):1077-88. PubMed ID: 22103667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin.
    Herrera LC; Shastri VP
    Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing.
    Tseng SJ; Tang SC
    Bioconjug Chem; 2007; 18(5):1383-90. PubMed ID: 17567100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modification of siRNA.
    Chernolovskaya EL; Zenkova MA
    Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA nunchucks with a hydrophobic linker for efficient intracellular delivery.
    Jo SD; Kim JS; Joe CO; Mok H; Nam YS
    Macromol Biosci; 2014 Feb; 14(2):195-201. PubMed ID: 24106091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular internalization and gene silencing of siRNA polyplexes by cytocleavable cationic polyrotaxanes with tailored rigid backbones.
    Tamura A; Yui N
    Biomaterials; 2013 Mar; 34(10):2480-91. PubMed ID: 23332177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles.
    Tamura A; Nagasaki Y
    Nanomedicine (Lond); 2010 Sep; 5(7):1089-102. PubMed ID: 20874023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically synthetic protein-based cationic polymer for siRNA delivery.
    Liu Y; Jia Z; Li L; Chen F
    Med Hypotheses; 2011 Feb; 76(2):239-40. PubMed ID: 21041034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimeric siRNA for Efficient Gene Silencing.
    Hong CA; Eltoukhy AA; Lee H; Langer R; Anderson DG; Nam YS
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6740-4. PubMed ID: 25892329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.